Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 750 participants.
Also called NCT07449910
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 750 participants
- Registry
-
NCT07449910
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07449910. Randomized; quadruple masking; primary purpose treatment. Start 2026-03-17 (anticipated); primary completion 2027-08-17 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial
- Condition
- Acute Ichemic Stroke
- Condition
- Anterior Cerebral Artery Stroke
- Condition
- Baricitinib
- Intervention (Drug)
- 2mg Baricitinib
- Intervention (Drug)
- 4mg Baricitinib
- Intervention (Drug)
- Placebo
- Intervention (Other)
- Guideline-based therapy
- Lead sponsor
- The First Affiliated Hospital of University of Science and Technology of China
Record details
- Record id
cardio:ct-nct07449910- Content hash
60b0bcb518203649cbc8d7498a63deffbb7e47fc2788aff1186718f3b65b1034